Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18,349 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[No title available]
[No authors listed] [No authors listed] PMID: 32541572
Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET.
François B, Fiancette M, Helms J, Mercier E, Lascarrou JB, Kayanoki T, Tanaka K, Fineberg D, Vincent JL, Wittebole X. François B, et al. Among authors: tanaka k. Ann Intensive Care. 2021 Mar 31;11(1):53. doi: 10.1186/s13613-021-00842-4. Ann Intensive Care. 2021. PMID: 33788052 Free PMC article.
Safety Profiles, Pharmacokinetics, and Changes in Bone Turnover Markers After Twice-Weekly Subcutaneous Administration of Teriparatide in Healthy Japanese Postmenopausal Women: A Single-Blind Randomized Study.
Kumagai Y, Ose A, Tanaka K, Sugimoto T. Kumagai Y, et al. Among authors: tanaka k. Clin Pharmacol Drug Dev. 2020 Jan;9(1):87-96. doi: 10.1002/cpdd.687. Epub 2019 Mar 28. Clin Pharmacol Drug Dev. 2020. PMID: 30921502 Free PMC article. Clinical Trial.
One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular degeneration in Japan.
Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M, Watanabe Y, Yamamoto A, Wakatsuki Y, Onoe H, Wakugawa S, Terao N, Hasegawa T, Kawai M, Maruko R, Itagaki K, Honjo J, Okada AA, Mori R, Koizumi H, Iida T, Sekiryu T. Mukai R, et al. Among authors: tanaka k. Sci Rep. 2024 May 22;14(1):11681. doi: 10.1038/s41598-024-62559-1. Sci Rep. 2024. PMID: 38778065
Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity.
Miyamoto S, Niizato D, Tomomasa D, Nishimura A, Hoshino A, Kamiya T, Isoda T, Takagi M, Kajiwara M, Azumi S, Hirabayashi S, Sakamoto K, Kishimoto K, Miyamura T, Umeda K, Hirose A, Keino D, Yanagimachi M, Kanda K, Sakai Y, Ikawa Y, Watanabe K, Tanaka K, Mori T, Ichinohe T, Sakaguchi H, Morio T, Kanegane H. Miyamoto S, et al. Among authors: tanaka k. J Clin Immunol. 2024 May 22;44(6):126. doi: 10.1007/s10875-024-01734-5. J Clin Immunol. 2024. PMID: 38773000
Developing a membrane-proximal CD33-targeting CAR T cell.
Freeman R, Shahid S, Khan AG, Mathew SC, Souness S, Burns ER, Um JS, Tanaka K, Cai W, Yoo S, Dunbar A, Park Y, McAvoy D, Hosszu KK, Levine RL, Boelens JJ, Lorenz IC, Brentjens RJ, Daniyan AF. Freeman R, et al. Among authors: tanaka k. J Immunother Cancer. 2024 May 20;12(5):e009013. doi: 10.1136/jitc-2024-009013. J Immunother Cancer. 2024. PMID: 38772686 Free PMC article.
18,349 results
You have reached the last available page of results. Please see the User Guide for more information.